Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1

Molecular and Cellular Biology

Volumn 20, Issue 6, 2000, Pages 2014-2022

  Koziczak, Magdalena ^a   Krek, Wilhelm ^a   Nagamine, Yoshikuni ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F; UROKINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SWINE; TRANSCRIPTION REGULATION;

ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; SUS SCROFA;

EID: 0033993923     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.6.2014-2022.2000     Document Type: Article

References (68)

1. Andreasen, P. A., L. Kjoller, L. Christensen, and M. J. Duffy. 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72:1-22.
2. Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55:875-885.
3. Avantaggiati, M. L., V. Ogryzko, K. Gardner, A. Giordano, A. S. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175-1184.
4. Bannister, A. J., and T. Kouzarides. 1995. CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14:4758-4762.
5. Bannister, A. J., T. Oehler, D. Wilhelm, P. Angel, and T. Kouzarides. 1995. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11:2509-2514.
6. Besser, D., M. Presta, and Y. Nagamine. 1995. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ. 6:1009-1017.
7. Besser, D., P. Verde, Y. Nagamine, and F. Blasi. 1996. Signal transduction and the u-PA/u-PAR system. Fibrinolysis 10:215-237.
8. Boehm, J. R., S. M. Kutz, E. H. Sage, L. Staiano-Coico, and P. J. Higgins. 1999. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1. J. Cell. Physiol 181:96-106.
9. Brehm, A., E. A. Miska, D. J, McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
10. Carmeliet, P., L. Moons, R. Lijnen, S. Janssens, F. Lupu, D. Collen, and R. D. Gerard. 1997. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 96:3180-3191.
11. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424.
12. Cassady, A. I., K. J. Stacey, K. A. Nimmo, K. M. Murphy, D. von der Ahe, D. Pearson, F. M. Botteri, Y. Nagamine, and D. A. Hume. 1991. Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5′ non-coding sequences that are conserved between mouse and pig. Nucleic Acids Res. 19:6839-6847.
13. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
14. Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392-2404.
15. Cousin, E., H. L. Medcalf, G. E. Bergonzelli, and E. K. Kruithof. 1991. Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 19:3881-3886.
16. DeGregori, J., G. Leone, A Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245-7250.
17. D'Orazio, D., D. Besser, R. Marksilzer, C. Kunz, D. A. Hume, B. Kiefer, and Y. Nagamine. 1997. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 201:179-187.
18. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
19. Gaubatz, S., J. G. Wood, and D. M. Livingston. 1998. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA 95:9190-9195.
20. Good, L., G. P. Dimri, J. Campisi, and K. Y. Chen. 1996. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence. J. Cell. Physiol. 168:580-588.
21. Grimaldi, G., P. Di Fiore, E. K. Locatelli, J. Falco, and F. Blasi. 1986. Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells. EMBO J. 5:855-861.
22. Hagemeier, C., A. Cook, and T. Kouzarides. 1993. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21:4998-5004.
23. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28-35.
24. Helin, K., E. Harlow, and A. Fattaey. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13: 6501-6508.
25. Herrin, D. L., and G. W. Schmidt. 1988. Rapid, reversible staining of Northern blots prior to hybridization. BioTechniques 6:196-200.
26. Huet, X., J. Rech, A. Plet, A. Vie, and J. M. Blanchard. 1996. Cyclin A expression is under negative transcriptional control during the cell cycle. Mol. Cell. Biol. 16:3789-3798.
27. Irigoven, J. P., P. Munoz-Canoves, L. Montera, M. Koziczak, and Y. Nagamine. 1999. The plasminogen activator system: biology and regulation. Cell. Mol. Life Sci. 56:104-132.
28. Johnson, D. G., K. Ohtani, and J. R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1514-1525.
29. Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352.
30. Karlseder, J., H. Rotheneder, and E. Wintersberger. 1996. Interaction of Sp1 with the growth-and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16:1659-1667.
31. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Raelin, Jr., and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
32. Kunz, C., S. Pebler, J. Otte, and D. von der Ahe. 1995. Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res. 23:3710-3717.
33. 1 events in serum-stimulated rat kidney cells. J. Cell. Physiol. 170:8-18.
34. Lam, E. W., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705-2713.
35. Lavia, P., and P. Jansen-Dürr. 1999. E2F target genes and cell-cycle checkpoint control. Bioessays 21:221-230.
36. Lee, J. S., D. von der Ahe, B. Kiefer, and Y. Nasamine. 1993. Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells. Nucleic Acids Res. 21: 3365-3372.
37. Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813-7825.
38. Leone, G., J. DeGregori, Z. Yan, L. Jakoi, S. Ishida, R. S. Williams, and J. R. Nevins. 1998. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12:2120-2130.
39. Lindeman, G. J., S. Gaubatz, D. M. Livingston, and D. Ginsberg. 1997. The subcellular localization of E2F-4 is cell-cycle dependent. Proc. Natl. Acad. Sci. USA 94:5095-5100.
40. Martin, K., D. Trouche, C. Hagemeier, T. S. Sorensen, N. B. La Thangue, and T. Kouzarides. 1995. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375:691-694.
41. McMahon, S. B., H. A. Van Buskirk, K. A. Dugan, T. D. Copeland, and M. D. Cole. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94:363-374.
42. Medcalf, R. L., M. Ruegg, and W. D. Schleuning. 1990. A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP. J. Biol. Chem. 265:14618-14626.
43. Messerschmitt, A., C. Disela, S. Dilworth, A. G. Marti, and K. Ballmer-Hofer. 1996. Polyomavirus middle-T antigen lacking a membrane anchor sequence accumulates in the nucleus. J. Gen. Virol. 77:17-26.
44. Moberg, K., M. A. Starz, and J. A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436-1449.
45. Morishita, R., G. H. Gibbons, M. Horiuchi, K. E. Ellison, M. Nakama, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. 1995. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA 92:5855-5859.
46. Mu, X. C., and P. J. Higgins. 1995. Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts. J. Cell. Physiol. 165:647-657.
47. Mu, X. C., L. Staiano-Coico, and P. J. Higgins. 1998. Increased transcription and modified growth state-dependent expression of the plasminogen activator inhibitor type-1 gene characterize the senescent phenotype in human diploid fibroblasts. J. Cell. Physiol. 174:90-98.
48. Nagamine, Y., J. S. Lee, P.-A. Menoud, and R. Nanbu. 1995. Structure and function of the urokinase-type plasminogen activator gene, p. 10-20. In P. Glas-Grenwalt (ed.), Fibrinolysis in disease. CRC Press, Boca Raton, Fla.
49. Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585-593.
50. Pearson, A., and J. Greenblatt. 1997. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene 15:2643-2658.
51. Qin, X. Q., D. M. Livingston, M. Ewen, W. R. Sellers, Z. Arany, and W. G. Kaelin, Jr. 1995. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15:742-755.
52. Riccio, A., L. R. Lund, R. Sartorio, A. Lania, P. A. Andreasen, K. Dano, and F. Blasi. 1988. The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene. Nucleic Acids Res. 16:2805-2824.
53. Robertson, K. D., and P. A. Jones. 1998. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol. 18:6457-6473.
54. Romer, J., T. H. Bugge, C. Pyke, L. R. Lund, M. J. Flick, J. L. Degen, and K. Dano. 1996. Impaired wound healing in mice with a disrupted plasminogen gene. Nat. Med. 2:287-292.
55. Ryan, M. P., S. M. Kutz, and P. J. Higgins. 1996. Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion. Biochem. J. 314:1041-1046.
56. Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R. A. Weinberg. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403-2407.
57. Schwarz, J. K., C. H. Bassing, I. Kovesdi, M. B. Datto, M. Blazing, S. George, X. F. Wang, and J. R. Nevins. 1995. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc. Natl. Acad. Sci. USA 92:483-487.
58. Shin, E. K., S. G. Tevosian, and A. S. Yee. 1996. The N-terminal region of E2F-1 is required for transcriptional activation of a new class of target promoter. J. Biol. Chem. 271:12261-12268.
59. Tiemann, F., and P. W. Hinds. 1998. Induction of DNA synthesis and apoptosis by regulated inactivation of a temperature-sensitive retinoblastoma protein. EMBO J. 17:1040-1052.
60. Trimarchi, J. M., B. Fairchild, R. Verona, K. Moberg, N. Andon, and J. A. Lees. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95:2850-2855.
61. Trouche, D., and T. Kouzarides. 1996. E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc. Natl. Acad. Sci. USA 93:1439-1442.
62. van Zonneveld, A. J., S. A. Curriden, and D. J. Loskutoff. 1988. Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc. Natl. Acad. Sci. USA 85:5525-5529.
63. 0 exit of resting mouse embryo fibroblasts. Proc. Natl. Acad. Sci. USA 95:15583-15586.
64. Weintraub, S. J., K. N. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815.
65. Wu, C. L., L. R. Zukerberg, C. Ngwu, E. Harlow, and J. A. Lees. 1995. In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15:2536-2546.
66. Zavizion, B., J. H. White, and A. J. Bramley. 1998. Cell cycle-dependent fluctuation of urokinase-type plasminogen activator, its receptor, and inhibitors in cultured bovine mammary epithelial and myoepithelial cells. Biochim. Biophys. Acta 1403:141-150.
67. 1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell 97:53-61.
68. Ziegler, A., J. Knesel, D. Fabbro, and Y. Nagamine. 1991. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. J. Biol. Chem. 266:21067-21074.